Eric Weisblum

CIK: 0001569077

Transaction Breakdown

Open Market Buys (P)10 (90.9%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (9.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SILO

Silo Pharma, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

SILO
Silo Pharma, Inc.
Dec 15, 2025
Purchase(P)
Direct
2.5K shares at avg. $0.41$1K
SILO
Silo Pharma, Inc.
Dec 15, 2025
Purchase(P)
Direct
2.5K shares at avg. $0.42$1K
SILO
Silo Pharma, Inc.
Nov 21, 2025
Purchase(P)
Direct
1K shares at avg. $0.36$365
SILO
Silo Pharma, Inc.
Nov 20, 2025
Purchase(P)
Direct
1K shares at avg. $0.37$370
SILO
Silo Pharma, Inc.
Nov 19, 2025
Purchase(P)
Direct
4.5K shares at avg. $0.41$2K
SILO
Silo Pharma, Inc.
Nov 18, 2025
Purchase(P)
Direct
7.5K shares at avg. $0.40$3K
SILO
Silo Pharma, Inc.
May 27, 2025
Purchase(P)
Direct
10K shares at avg. $0.43$4K
SILO
Silo Pharma, Inc.
May 23, 2025
Award(A)
Options (right to buy)
Direct
200K shares-
SILO
Silo Pharma, Inc.
Dec 13, 2024
Purchase(P)
Direct
2.5K shares at avg. $0.84$2K
SILO
Silo Pharma, Inc.
Nov 22, 2024
Purchase(P)
Direct
2.5K shares at avg. $0.90$2K
SILO
Silo Pharma, Inc.
Nov 20, 2024
Purchase(P)
Direct
2.5K shares at avg. $0.95$2K

		Type	Shares	Price		Ownership
Dec 15, 2025	SILO Silo Pharma, Inc.	Purchase(P)	2,500	$0.41	$1,025	Direct
Dec 15, 2025	SILO Silo Pharma, Inc.	Purchase(P)	2,500	$0.42	$1,050	Direct
Nov 21, 2025	SILO Silo Pharma, Inc.	Purchase(P)	1,000	$0.36	$365	Direct
Nov 20, 2025	SILO Silo Pharma, Inc.	Purchase(P)	1,000	$0.37	$370	Direct
Nov 19, 2025	SILO Silo Pharma, Inc.	Purchase(P)	4,500	$0.41	$1,823	Direct
Nov 18, 2025	SILO Silo Pharma, Inc.	Purchase(P)	7,500	$0.40	$3,025	Direct
May 27, 2025	SILO Silo Pharma, Inc.	Purchase(P)	10,000	$0.43	$4,329	Direct
May 23, 2025	SILO Silo Pharma, Inc.	Award(A) Options (right to buy)	200,000	-	-	Direct
Dec 13, 2024	SILO Silo Pharma, Inc.	Purchase(P)	2,500	$0.84	$2,097	Direct
Nov 22, 2024	SILO Silo Pharma, Inc.	Purchase(P)	2,500	$0.90	$2,250	Direct
Nov 20, 2024	SILO Silo Pharma, Inc.	Purchase(P)	2,500	$0.95	$2,375	Direct

1-11 of 11 transactions

About Weisblum Eric

Weisblum Eric (SEC CIK 0001569077) files insider reports with the SEC as CEO and President of Silo Pharma, Inc. (SILO).

Signal8 holds 7 ownership filings by Weisblum Eric, all Form 4s, filed between Nov 22, 2024 and Dec 16, 2025. Those filings report 11 transactions, from Nov 20, 2024 to Dec 15, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Weisblum Eric's filings is in SARASOTA, FL.

Recent filings by Weisblum Eric

Dec 15, 2025: Open-market purchases of SILO shares (2 lines, Form 4, code P).
Nov 21, 2025: Open-market purchase of SILO shares (Form 4, code P).
Nov 20, 2025: Open-market purchase of SILO shares (Form 4, code P).
Nov 19, 2025: Open-market purchase of SILO shares (Form 4, code P).
Nov 18, 2025: Open-market purchase of SILO shares (Form 4, code P).

Other insiders filing for Silo Pharma, Inc. (SILO)

Linsley Wayne, Director
Munoz Kevin, Director
Ryweck Daniel E., Chief Financial Officer
Pavell Jeff, Director

How to read Form 4 transaction codes